Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016

[1]  C. Bernardo,et al.  Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018 , 2021, The Australian and New Zealand journal of psychiatry.

[2]  Huali Wang,et al.  Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study , 2021, Frontiers in Psychiatry.

[3]  H. Gesesew,et al.  Migrants and Service Providers’ Perspectives of Barriers to Accessing Mental Health Services in South Australia: A Case of African Migrants with a Refugee Background in South Australia , 2021, International journal of environmental research and public health.

[4]  David Taylor,et al.  An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression. , 2021, Journal of child and adolescent psychopharmacology.

[5]  E. Aronen,et al.  New Users of Antipsychotics Among Children and Adolescents in 2008–2017: A Nationwide Register Study , 2020, Frontiers in Psychiatry.

[6]  M. Ruggeri,et al.  Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care? , 2020, International Journal of Mental Health Systems.

[7]  G. Trifirò,et al.  ‘Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study’ , 2020, Epidemiology and Psychiatric Sciences.

[8]  R. Mulder,et al.  Psychotropic Medication Prescription Rates and Trends for New Zealand Children and Adolescents 2008-2016. , 2020, Journal of child and adolescent psychopharmacology.

[9]  M. Bonati,et al.  Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data , 2019, European Journal of Clinical Pharmacology.

[10]  Sudha R. Raman,et al.  Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. , 2018, The lancet. Psychiatry.

[11]  M. Lapeyre-Mestre,et al.  Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database , 2018, Journal of clinical psychopharmacology.

[12]  J. Iida,et al.  Prevalence, incidence and persistence of ADHD drug use in Japan , 2018, Epidemiology and Psychiatric Sciences.

[13]  D. Shang,et al.  Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study , 2018, International clinical psychopharmacology.

[14]  Lisa M. Schwartz,et al.  Psychotropic medications for highly vulnerable children , 2018, Expert opinion on pharmacotherapy.

[15]  E. Garbe,et al.  Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011. , 2017, Journal of child and adolescent psychopharmacology.

[16]  E. Garbe,et al.  Extent and risks of antidepressant off‐label use in children and adolescents in Germany between 2004 and 2011 , 2017, Pharmacoepidemiology and drug safety.

[17]  G. Glaeske,et al.  Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012 , 2017, European Neuropsychopharmacology.

[18]  O. Bonnot,et al.  Influence of socioeconomic status on antipsychotic prescriptions among youth in France , 2017, BMC Psychiatry.

[19]  S. Hodgkinson,et al.  Improving Mental Health Access for Low-Income Children and Families in the Primary Care Setting , 2017, Pediatrics.

[20]  B. Inder,et al.  Mental disorders and distress: Associations with demographics, remoteness and socioeconomic deprivation of area of residence across Australia , 2016, The Australian and New Zealand journal of psychiatry.

[21]  I. Song,et al.  Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011 , 2016, Epidemiology and health.

[22]  J. Korevaar,et al.  ADHD medication prescription , 2016, Journal of child health care : for professionals working with children in the hospital and community.

[23]  S. Kanba,et al.  Prescribing Pattern of Antidepressants in Children and Adolescents: Findings from the Research on Asia Psychotropic Prescription Pattern. , 2016, East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan.

[24]  I. Petersen,et al.  Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012 , 2016, European Neuropsychopharmacology.

[25]  J. Hanley,et al.  Association of Off-label Drug Use and Adverse Drug Events in an Adult Population. , 2016, JAMA internal medicine.

[26]  Andrew J. Lewis,et al.  Gender differences in adolescent depression: Differential female susceptibility to stressors affecting family functioning , 2015 .

[27]  I. McGregor,et al.  Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty , 2014, The Australian and New Zealand journal of psychiatry.

[28]  S. O'Hanrahan,et al.  Paediatric psychotropic prescribing practices in Ireland , 2014, Irish Journal of Psychological Medicine.

[29]  K. Merikangas,et al.  Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  Christopher M. Burkle,et al.  Ten common questions (and their answers) about off-label drug use. , 2012, Mayo Clinic proceedings.

[31]  B. Margetić,et al.  Outpatient treatment of children and adolescents with antidepressants in Croatia , 2012, International journal of psychiatry in clinical practice.

[32]  Anthony F Jorm,et al.  Belief in the harmfulness of antidepressants: associated factors and change over 16 years. , 2012, Journal of affective disorders.

[33]  J. Charles,et al.  Management of Children's Psychological Problems in General Practice 1970–1971, 1990–1991 and 2008–2009 , 2011, The Australian and New Zealand journal of psychiatry.

[34]  Kathleen R. Merikangas,et al.  Prevalence and Treatment of Mental Disorders Among US Children in the 2001–2004 NHANES , 2010, Pediatrics.

[35]  Wayne M Glines,et al.  Epidemiology of mental disorders in children and adolescents , 2009, Dialogues in clinical neuroscience.

[36]  Fariz A. Rani,et al.  Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom , 2008, Pediatrics.

[37]  M. Shumway,et al.  Access to Mental Health Treatment by English Language Proficiency and Race/Ethnicity , 2007, Journal of General Internal Medicine.

[38]  Gitanjali Saluja,et al.  Prevalence of and risk factors for depressive symptoms among young adolescents. , 2004, Archives of pediatrics & adolescent medicine.

[39]  Andrés Martin,et al.  Datapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children. , 2002, Psychiatric services.

[40]  Kimberly Hoagwood,et al.  Development and natural history of mood disorders , 2002, Biological Psychiatry.

[41]  David M. Fergusson,et al.  The Christchurch Health and Development Study: Review of Findings on Child and Adolescent Mental Health , 2001, The Australian and New Zealand journal of psychiatry.

[42]  Organización Mundial de la Salud.  Guidelines for ATC classification and DDD assignment , 1996 .